Orum Therapeutics, Inc.
Clinical-stage biotech developing degrader-antibody conjugates to treat cancer.
475830 | KO
Overview
Corporate Details
- ISIN(s):
- KR7475830006
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 문지로 281-25, 대전광역시
- Website:
- https://www.orumrx.com/
Description
Orum Therapeutics is a clinical-stage biotechnology company that develops targeted protein degradation (TPD) therapeutics. The company's proprietary TPD²® platform creates a novel class of antibody-drug conjugates (ADCs), referred to as degrader-antibody conjugates (DACs). This technology combines the cell-targeting precision of antibodies with the catalytic action of protein degraders. The approach is designed to selectively deliver payloads to diseased cells to eliminate intracellular proteins that are difficult to target with conventional drugs. Orum's primary focus is on developing treatments for cancer, aiming to improve efficacy and safety over existing therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-29 00:00 |
철회신고서
|
Korean | 4.1 KB | ||
| 2024-11-27 00:00 |
투자설명서
|
Korean | 3.2 MB | ||
| 2024-11-20 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.5 MB | ||
| 2024-11-14 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 3.5 MB | ||
| 2024-11-05 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 4.6 MB | ||
| 2024-10-02 00:00 |
[첨부추가]증권신고서(지분증권)
|
Korean | 3.0 MB | ||
| 2024-04-01 00:00 |
감사보고서 (2023.12)
|
Korean | 474.5 KB | ||
| 2024-04-01 00:00 |
연결감사보고서 (2023.12)
|
Korean | 500.7 KB | ||
| 2023-04-06 00:00 |
감사보고서 (2022.12)
|
Korean | 192.1 KB | ||
| 2023-04-06 00:00 |
연결감사보고서 (2022.12)
|
Korean | 190.1 KB |
Automate Your Workflow. Get a real-time feed of all Orum Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Orum Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Orum Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
